CLTCL1: A Potential Drug Target for Cell Signaling Pathways (G8218)

Target Name: CLTCL1

NCBI ID: G8218

CLTCL1

CLTCL1: A Potential Drug Target for Cell Signaling Pathways

CLTCL1, also known as Clathrin heavy chain 2 (ISOform 1), is a protein that is expressed in various tissues throughout the body. It plays a critical role in the structure and function of cells, particularly in the regulation of cell signaling pathways. CLTCL1 has been identified as a potential drug target and may also be used as a biomarker for certain diseases.

CLTCL1 is a member of the clathrin family, which is known for their role in regulating cell signaling pathways. Clathrins are a type of protein that can form a cube-shaped structure in solution, which is important for their ability to interact with and transport various signaling molecules. CLTCL1 is characterized by its ability to form a stable and functional cube-shaped structure, as well as its role in regulating the production of certain signaling molecules.

CLTCL1 is involved in the regulation of several different signaling pathways, including the TGF-β pathway and the NF-kappa-B pathway. TGF-β is a well-known signaling pathway that is involved in the regulation of cell growth, differentiation, and inflammation. The TGF-β pathway is a complex signaling pathway that is regulated by multiple proteins, including CLTCL1. CLTCL1 plays a critical role in the regulation of TGF-β signaling by ensuring that the signaling molecule, transforming growth factor-尾1 (TGF-β1), is properly produced and can function properly.

CLTCL1 is also involved in the regulation of the NF-kappa-B pathway, which is a signaling pathway that is involved in the regulation of inflammation and immune responses. The NF-kappa-B pathway is activated by various signaling molecules, including TNF-伪 and IL-1尾. CLTCL1 plays a critical role in the regulation of the NF-kappa-B pathway by ensuring that the signaling molecule, NF-kappa-B ligand (NF-kappa-B), is properly produced and can function properly.

In addition to its role in regulating TGF-β and NF-kappa-B signaling pathways, CLTCL1 is also involved in the regulation of cell adhesion. CLTCL1 is a component of the cadherin protein family, which is known for their role in cell-cell adhesion. CLTCL1 plays a critical role in the regulation of cadherin-based signaling pathways by ensuring that the signaling molecule, cadherin, is properly produced and can function properly.

CLTCL1 has also been identified as a potential drug target for several diseases. For example, CLTCL1 has been shown to be involved in the development and progression of certain types of cancer, including breast cancer and lung cancer. Additionally, CLTCL1 has been shown to be involved in the regulation of the immune response, which is a critical function of the body's immune system.

CLTCL1 may also be used as a biomarker for certain diseases. For example, CLTCL1 has been shown to be involved in the regulation of the growth and differentiation of certain types of cells, which may be used as a biomarker for certain types of cancer, such as breast cancer. Additionally, CLTCL1 has been shown to play a critical role in the regulation of the immune response, which may be used as a biomarker for certain types of autoimmune diseases, such as rheumatoid arthritis and lupus.

In conclusion, CLTCL1 is a protein that is involved in the regulation of several different signaling pathways, including TGF-β and NF-kappa-B pathways. CLTCL1 has been identified as a potential drug target for several diseases, including cancer and autoimmune diseases. Further research is needed to fully understand the role of CLTCL1 in the regulation of cell signaling pathways and its potential as a drug

Protein Name: Clathrin Heavy Chain Like 1

Functions: Clathrin is the major protein of the polyhedral coat of coated pits and vesicles. Two different adapter protein complexes link the clathrin lattice either to the plasma membrane or to the trans-Golgi network (By similarity)

The "CLTCL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CLTCL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets